• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Apr 15, 2017
Product Development

Outside factors

How new hemophilia products could usher in personalized treatment strategies
Read More
BioCentury | Sep 28, 2015
Emerging Company Profile

Microparticle man

RxMP's microparticles may be safer hemostats by speeding, not starting clotting
Read More
BioCentury | Sep 14, 2015
Clinical News

Factor VIIa-albumin fusion protein: Phase II/III started

Read More
BioCentury | May 20, 2013
Clinical News

BAY 86-6150: Phase II/III discontinued

Read More
BioCentury | Feb 11, 2013
Clinical News

Prolor preclinical data

Read More
BioCentury | Dec 3, 2012
Clinical News

BAY 86-6150: Phase II/III ongoing

Read More
Items per page:
1 - 6 of 6